Millrace Asset Group, Inc. Neuronetics, Inc. Transaction History

Millrace Asset Group, Inc.

$99.5 Million
Q1 2024

A detailed history of Millrace Asset Group, Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 756,804 shares of STIM stock, worth $1.36 Million. This represents 3.62% of its overall portfolio holdings.

Number of Shares

756,804

Previous 725,369 4.33%

Holding current value

$1.36 Million

Previous $2.1 Million 71.2%

% of portfolio

3.62%

Previous 2.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.68 - $4.8 $84,245 - $150,888	31,435 Added 4.33%	756,804 $3.6 Million
Q4 2023 Feb 12, 2024	BUY	$1.05 - $2.9 $511,970 - $1.41 Million	487,591 Added 205.06%	725,369 $2.1 Million
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $197,815 - $340,425	-153,345 Reduced 39.21%	237,778 $321,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $505,253 - $712,725	-244,084 Reduced 38.43%	391,123 $841,000
Q1 2023 May 11, 2023	BUY	$2.81 - $6.71 $104,596 - $249,766	37,223 Added 6.22%	635,207 $1.85 Million

Q4 2022 Feb 13, 2023	SELL	$3.44 - $6.87 $163,114 - $325,754	-47,417 Reduced 7.35%	597,984 $4.11 Million
Q3 2022 Oct 31, 2022	BUY	$2.35 - $4.66 $36,824 - $73,022	15,670 Added 2.49%	645,401 $2.05 Million
Q2 2022 Jul 28, 2022	BUY	$2.09 - $3.71 $291,335 - $517,155	139,395 Added 28.43%	629,731 $2.02 Million
Q1 2022 May 04, 2022	BUY	$2.84 - $4.52 $1.08 Million - $1.71 Million	378,588 Added 338.79%	490,336 $1.49 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $514 - $876	133 Added 0.12%	111,748 $498,000
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $502,488 - $1.26 Million	-80,786 Reduced 41.99%	111,615 $732,000
Q2 2021 Aug 11, 2021	BUY	$10.15 - $17.25 $519,964 - $883,683	51,228 Added 36.29%	192,401 $3.08 Million
Q1 2021 May 12, 2021	SELL	$10.6 - $21.27 $1.15 Million - $2.32 Million	-108,848 Reduced 43.54%	141,173 $1.75 Million
Q4 2020 Feb 11, 2021	SELL	$4.95 - $11.45 $1.34 Million - $3.11 Million	-271,314 Reduced 52.04%	250,021 $2.78 Million
Q3 2020 Nov 17, 2020	BUY	$1.82 - $5.87 $411,179 - $1.33 Million	225,923 Added 76.48%	521,335 $2.53 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.61 $416,530 - $771,025	295,412 New	295,412 $570,000
Q2 2019 Aug 13, 2019	SELL	$9.0 - $17.2 $1.13 Million - $2.15 Million	-125,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$13.6 - $19.58 $1.7 Million - $2.45 Million	125,000 New	125,000 $1.91 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.

Account

Millrace Asset Group, Inc. Neuronetics, Inc. Transaction History